Que Dallara on Medtronic’s diabetes spinoff, pipeline and Abbott partnership

By /

Dallara, president of Medtronic’s diabetes business, discussed the segment’s turnaround and why she sees a benefit in becoming a standalone firm.

Scroll to Top